-
Je něco špatně v tomto záznamu ?
Prolactin-releasing peptide: a new tool for obesity treatment
J. Kuneš, V. Pražienková, A. Popelová, B. Mikulášková, J. Zemenová, L. Maletínská,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, přehledy
PubMed
27418033
DOI
10.1530/joe-16-0046
Knihovny.cz E-zdroje
- MeSH
- hormon uvolňující prolaktin analogy a deriváty terapeutické užití MeSH
- látky proti obezitě farmakologie terapeutické užití MeSH
- lékové transportní systémy * MeSH
- lidé MeSH
- obezita farmakoterapie MeSH
- regulace chuti k jídlu * MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Obesity is an escalating epidemic, but an effective noninvasive therapy is still scarce. For obesity treatment, anorexigenic neuropeptides are promising tools, but their delivery from the periphery to the brain is complicated because peptides have a low stability and limited ability to cross the blood-brain barrier. In this review, we summarize results of several studies with our newly designed lipidized analogs of prolactin-releasing peptide (PrRP). PrRP is involved in feeding and energy balance regulation as demonstrated by obesity phenotypes of both PrRP- and PrRP-receptor-knockout mice. Lipidized PrRP analogs showed binding affinity and signaling in PrRP receptor-expressing cells similar to natural PrRP. Moreover, these analogs showed high binding affinity also to anorexigenic neuropeptide FF (NPFF)-2 receptor. Acute peripheral administration of myristoylated and palmitoylated PrRP analogs to mice and rats induced strong and long-lasting anorexigenic effects and neuronal activation in the brain areas involved in food intake regulation. Two-week-long subcutaneous administration of palmitoylated PrRP31 and myristoylated PrRP20 lowered food intake, body weight, improved metabolic parameters and attenuated lipogenesis in mice with diet-induced obesity. A strong anorexigenic, body weight-reducing and glucose tolerance-improving effect of palmitoylated-PrRP31 was shown also in diet-induced obese rats after its repeated 2-week-long peripheral administration. Thus, the strong anorexigenic and body weight-reducing effects of palmitoylated PrRP31 and myristoylated PrRP20 make these analogs attractive candidates for antiobesity treatment. Moreover, PrRP receptor might be a new target for obesity therapy.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17023850
- 003
- CZ-PrNML
- 005
- 20170830100930.0
- 007
- ta
- 008
- 170720s2016 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1530/JOE-16-0046 $2 doi
- 035 __
- $a (PubMed)27418033
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Kuneš, Jaroslav $u Institute of Organic Chemistry and BiochemistryAcademy of Sciences of the Czech Republic, Prague, Czech Republic Institute of PhysiologyAcademy of Sciences of the Czech Republic, Prague, Czech Republic.
- 245 10
- $a Prolactin-releasing peptide: a new tool for obesity treatment / $c J. Kuneš, V. Pražienková, A. Popelová, B. Mikulášková, J. Zemenová, L. Maletínská,
- 520 9_
- $a Obesity is an escalating epidemic, but an effective noninvasive therapy is still scarce. For obesity treatment, anorexigenic neuropeptides are promising tools, but their delivery from the periphery to the brain is complicated because peptides have a low stability and limited ability to cross the blood-brain barrier. In this review, we summarize results of several studies with our newly designed lipidized analogs of prolactin-releasing peptide (PrRP). PrRP is involved in feeding and energy balance regulation as demonstrated by obesity phenotypes of both PrRP- and PrRP-receptor-knockout mice. Lipidized PrRP analogs showed binding affinity and signaling in PrRP receptor-expressing cells similar to natural PrRP. Moreover, these analogs showed high binding affinity also to anorexigenic neuropeptide FF (NPFF)-2 receptor. Acute peripheral administration of myristoylated and palmitoylated PrRP analogs to mice and rats induced strong and long-lasting anorexigenic effects and neuronal activation in the brain areas involved in food intake regulation. Two-week-long subcutaneous administration of palmitoylated PrRP31 and myristoylated PrRP20 lowered food intake, body weight, improved metabolic parameters and attenuated lipogenesis in mice with diet-induced obesity. A strong anorexigenic, body weight-reducing and glucose tolerance-improving effect of palmitoylated-PrRP31 was shown also in diet-induced obese rats after its repeated 2-week-long peripheral administration. Thus, the strong anorexigenic and body weight-reducing effects of palmitoylated PrRP31 and myristoylated PrRP20 make these analogs attractive candidates for antiobesity treatment. Moreover, PrRP receptor might be a new target for obesity therapy.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a látky proti obezitě $x farmakologie $x terapeutické užití $7 D019440
- 650 12
- $a regulace chuti k jídlu $7 D001069
- 650 12
- $a lékové transportní systémy $7 D016503
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a obezita $x farmakoterapie $7 D009765
- 650 _2
- $a hormon uvolňující prolaktin $x analogy a deriváty $x terapeutické užití $7 D056690
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Pražienková, Veronika $u Institute of Organic Chemistry and BiochemistryAcademy of Sciences of the Czech Republic, Prague, Czech Republic.
- 700 1_
- $a Popelová, Andrea $u Institute of Organic Chemistry and BiochemistryAcademy of Sciences of the Czech Republic, Prague, Czech Republic.
- 700 1_
- $a Mikulášková, Barbora $u Institute of Organic Chemistry and BiochemistryAcademy of Sciences of the Czech Republic, Prague, Czech Republic Institute of PhysiologyAcademy of Sciences of the Czech Republic, Prague, Czech Republic.
- 700 1_
- $a Zemenová, Jana $u Institute of Organic Chemistry and BiochemistryAcademy of Sciences of the Czech Republic, Prague, Czech Republic University of Chemistry and TechnologyPrague, Czech Republic.
- 700 1_
- $a Maletínská, Lenka $u Institute of Organic Chemistry and BiochemistryAcademy of Sciences of the Czech Republic, Prague, Czech Republic maletin@uochb.cas.cz.
- 773 0_
- $w MED00002653 $t The Journal of endocrinology $x 1479-6805 $g Roč. 230, č. 2 (2016), s. R51-8
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27418033 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20170830101519 $b ABA008
- 999 __
- $a ok $b bmc $g 1239531 $s 984763
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 230 $c 2 $d R51-8 $i 1479-6805 $m Journal of Endocrinology $n J Endocrinol $x MED00002653
- LZP __
- $a Pubmed-20170720
